Document Detail

Mechanisms and treatment of cancer cachexia.
MedLine Citation:
PMID:  22749678     Owner:  NLM     Status:  Publisher    
According to a recent consensus, cachexia is a complex metabolic syndrome associated with underlying illness and characterised by loss of muscle with or without loss of fat mass. The prominent clinical feature of cachexia is weight loss. Cachexia occurs in the majority of terminal cancer patients and it is responsible for the deaths of 22% of cancer patients. Although body weight is, indeed, an important factor to be taken into consideration in any cachexia treatment, body composition, physical performance and quality of life should be monitored. From the results presented here, one can speculate that a single therapy may not be completely successful in the treatment of cachexia. From this point of view, treatments involving different combinations are more likely to be successful. The objectives of any therapeutical combination are two: an anticatabolic aim directed towards both fat and muscle catabolism and an anabolic objective leading to the synthesis of macromolecules such as contractile proteins.
J M Argilés; F J López-Soriano; S Busquets
Related Documents :
16331348 - Screening mammography after breast cancer treatment: patterns in community practice.
1486368 - Improved image quality for dense breasts in mammography.
24122978 - Overcoming platinum drug resistance with copper-lowering agents.
9709288 - Mammography versus clinical examination of the breasts.
21536828 - A practical guide to prostate cancer diagnosis and management.
12734738 - Pseudo-meigs' syndrome caused by ovarian metastasis from colon cancer: report of a case.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-30
Journal Detail:
Title:  Nutrition, metabolism, and cardiovascular diseases : NMCD     Volume:  -     ISSN:  1590-3729     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-7-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111474     Medline TA:  Nutr Metab Cardiovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Cancer Research Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A brief history of anti-VEGF for the treatment of ocular angiogenesis.
Next Document:  Does salt intake in the first two years of life affect the development of cardiovascular disorders i...